≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other encephalitis

DOID EFO Endpoint Browser PheWeb

G6_ENCEPHOTH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

1004

4. Check minimum number of events

None

1004

5. Include endpoints

None

1004

6. Filter based on genotype QC (FinnGen only)

1004

Control definitions (FinnGen only)

Control exclude
G6_NEUINFL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8321 4179 4069
Only index persons 7092 3622 3470
Unadjusted period prevalence (%)
Whole population 0.12 0.12 0.11
Only index persons 0.13 0.13 0.13
Median age at first event (years)
Whole population 44.69 46.74 42.37
Only index persons 42.17 44.29 39.97

-FinnGen-

Key figures

All Female Male
Number of individuals 1004 555 449
Unadjusted period prevalence (%) 0.19 0.19 0.20
Median age at first event (years) 48.41 44.27 53.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
892
Matched controls
8918
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
6853.6
323.0
406
*
TAB00
NOMESCO Finland
Lumbar puncture
18.9
153.9
247
177
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
110.8
104
*
32309
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Unspecified
+∞
105.3
99
*
A86
ICD-10 Finland
Unspecified viral encephalitis
297.0
105.3
105
*
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
90.1
85
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.7
87.5
225
376
AA1AD
NOMESCO Finland
CT of head and brain
4.2
70.2
337
1128
XA800
NOMESCO Finland
Neuropsychological investigation
10.0
64.4
135
156
G40.9
ICD-10 Finland
Epilepsy, unspecified
13.6
62.3
111
92
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.3
60.6
142
198
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.4
59.1
106
89
N03AX14
ATC
levetiracetam; systemic
14.9
54.6
93
69
5AB01
NOMESCO Finland
NA
504.1
48.8
48
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.0
45.6
212
651
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
45.2
43
*
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
44.1
42
*
G05.1*J09
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses
+∞
43.1
41
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
12.7
40.3
73
62
ZX120
NOMESCO Finland
Intravenous
4.6
39.5
148
366
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.5
37.2
144
367
N03AF02
ATC
oxcarbazepine; oral
8.1
36.7
85
114
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.7
35.8
108
209
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
34.6
33
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
19.5
33.0
50
27
A87.9
ICD-10 Finland
Viral meningitis, unspecified
26.2
32.6
45
18
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
32.0
191
697
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.2
31.8
64
67
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
30.8
412
2397
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
+∞
30.4
29
*
G03.9
ICD-10 Finland
Meningitis, unspecified
+∞
30.4
29
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
+∞
30.4
29
*
R4120
NOMESCO Finland
Occupational therapy
4.6
29.8
109
260
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
29.8
235
1021
R50.9
ICD-10 Finland
Fever, unspecified
3.1
29.3
184
690
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
13.6
27.7
48
37
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.4
27.3
54
55
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
22.6
27.1
39
18
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
26.6
184
733
N03AG01
ATC
valproic acid; systemic, rectal
4.6
26.4
97
232
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.8
26.4
121
356
3238B
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]
+∞
26.2
25
*
A28
ICPC
Limited function/disability NOS
3.0
25.7
162
606
R4110
NOMESCO Finland
Physiotherapy
2.4
25.5
271
1375
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
16.0
24.8
40
26
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
23.9
124
402
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
48.1
23.4
28
6
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
23.2
177
743
R4150
NOMESCO Finland
Neuropsychological rehabilitation
19.1
23.2
35
19
N03AX12
ATC
gabapentin; oral
2.7
22.9
175
734
WX892
NOMESCO Finland
Monitored bed care
3.8
22.0
97
275
R20.2
ICD-10 Finland
Paraesthesia of skin
4.1
21.5
88
233
R41.0
ICD-10 Finland
Disorientation, unspecified
7.1
21.4
53
79
G35
ICD-10 Finland
Multiple sclerosis
7.7
20.9
49
67
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
20.7
223
1121
N03AX16
ATC
pregabalin; oral
2.3
20.5
236
1223
2AB04
NOMESCO Finland
NA
49.2
20.2
24
5
N03AX18
ATC
lacosamide; systemic
17.8
20.1
31
18
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
58.9
20.0
23
*
G05.1*J10.8
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus
+∞
19.9
19
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
19.9
19
*
R51.80
ICD-10 Finland
Headache
2.5
19.8
169
751
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
19.2
277
1580
183
Kela drug reimbursment
Lamotrigin and topiramate
14.4
19.2
32
23
6BA02
NOMESCO Finland
NA
35.2
19.0
24
7
N03AB02
ATC
phenytoin; systemic
13.2
18.5
32
25
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.1
18.4
106
369
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
18.2
138
572
TKC20
NOMESCO Finland
Catheterisation of bladder
3.6
18.1
86
259
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
17.8
75
204
N05BA09
ATC
clobazam; oral
16.0
17.6
28
18
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
12.9
17.2
30
24
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
16.7
16
*
R33
ICD-10 Finland
Retention of urine
3.3
16.5
87
284
XA400
NOMESCO Finland
EEG
18.3
16.5
25
14
H02AB06
ATC
prednisolone; systemic
1.8
16.5
412
2846
N99
ICPC
Neurological disease other
9.7
16.0
32
34
J01MA12
ATC
levofloxacin; systemic
2.3
16.0
167
818
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.1
15.7
43
74
H02AB07
ATC
prednisone; oral
2.4
15.6
144
662
F05.9
ICD-10 Finland
Delirium, unspecified
6.9
15.4
38
57
WW400
NOMESCO Finland
Plasmaferesis
45.8
15.1
18
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
15.1
142
658
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
16.8
14.8
23
14
N71
ICPC
Meningitis/encephalitis
+∞
14.6
14
*
L28
ICPC
Limited function/disability (L)
2.3
14.6
146
697
L04AX01
ATC
azathioprine; systemic
3.8
14.3
60
164
C03CA01
ATC
furosemide; systemic
2.0
14.2
223
1291
M05BA04
ATC
alendronic acid; oral
2.9
14.2
90
333
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.5
14.2
67
202
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
13.9
90
338
L04AA06
ATC
mycophenolic acid; systemic
6.4
13.9
36
58
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
24.2
13.8
19
8
R4130
NOMESCO Finland
Speech therapy
6.3
13.8
36
59
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
76.3
13.6
15
*
32308
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Alia definita
+∞
13.6
13
*
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
13.6
13
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.1
13.4
75
253
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
13.4
82
298
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
12.4
13.1
23
19
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.9
13.1
36
63
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
50.8
12.9
15
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
50.8
12.9
15
*
J01DB01
ATC
cefalexin; oral
1.8
12.8
709
6050
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.5
12.8
37
69
R42
ICD-10 Finland
Dizziness and giddiness
2.0
12.8
189
1065
109
Kela drug reimbursment
Multiple sclerosis
7.2
12.7
30
43
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.2
12.4
38
76
J05AB11
ATC
valaciclovir; oral
2.3
12.2
124
595
R11
ICD-10 Finland
Nausea and vomiting
2.7
12.1
86
341
N05BA01
ATC
diazepam; systemic, rectal
2.2
11.9
125
610
H02AB09
ATC
hydrocortisone; systemic
4.3
11.9
43
103
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
11.8
70
249
N03AF01
ATC
carbamazepine; oral, rectal
3.3
11.8
60
192
N03AX09
ATC
lamotrigine; oral
3.3
11.6
58
184
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
11.6
160
876
JN4BD
NOMESCO Finland
Extensive body CT
2.4
11.5
98
431
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
11.5
149
795
G41.9
ICD-10 Finland
Status epilepticus, unspecified
13.8
11.5
19
14
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
11.5
11
*
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
+∞
11.5
11
*
5CM18
NOMESCO Finland
NA
35.5
11.3
14
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
25.4
11.2
15
6
N28
ICPC
Limited function/disability (N)
8.4
10.8
23
28
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
10.8
78
313
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
10.7
84
353
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
10.6
83
347
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.1
10.6
25
36
N05CF01
ATC
zopiclone; oral
1.7
10.6
257
1698
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.6
10.6
22
26
A02BC02
ATC
pantoprazole; systemic
1.6
10.5
521
4168
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
10.4
10
*
R53
ICD-10 Finland
Malaise and fatigue
1.9
10.4
174
1017
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.5
10.4
26
41
G40.89
ICD-10 Finland
Other epilepsy
16.3
10.4
16
10
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
32.9
10.3
13
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
10.3
63
228
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.7
10.2
25
38
J01AA02
ATC
doxycycline; systemic
1.6
10.2
639
5408
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
10.0
42
116
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
9.9
87
387
G61.0
ICD-10 Finland
Guillain-Barré syndrome
20.3
9.8
14
7
N05AH04
ATC
quetiapine; oral
1.9
9.8
152
866
WX730
NOMESCO Finland
Conventional respirator
6.2
9.7
25
41
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.4
9.7
28
53
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
6.5
9.6
24
38
N03AX11
ATC
topiramate; oral
4.3
9.6
34
81
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
9.4
9
*
WX704
NOMESCO Finland
Intubation
2.5
9.1
71
297
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.1
9.1
21
30
F05.8
ICD-10 Finland
Other delirium
15.8
9.0
14
9
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
8.9
34
87
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
8.9
114
604
J01MA02
ATC
ciprofloxacin; systemic
1.6
8.9
300
2152
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
6.4
8.8
22
35
RS221
NOMESCO Finland
NA
5.4
8.8
25
47
SPAT1254
SPAT
Administration of medicine
1.9
8.8
132
743
A41.9
ICD-10 Finland
Sepsis, unspecified
3.6
8.6
37
105
A02BC01
ATC
omeprazole; systemic
1.7
8.6
212
1396
A69.2
ICD-10 Finland
Lyme disease
3.1
8.5
46
156
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.0
8.4
18
23
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
8.4
85
408
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.3
8.3
24
46
G05.1*J11.8
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis in suspected influenza
+∞
8.3
8
*
N02AA05
ATC
oxycodone; systemic
2.0
8.3
112
605
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.9
8.3
33
88
N06AX11
ATC
mirtazapine; oral
1.6
8.3
258
1806
J96.0
ICD-10 Finland
Acute respiratory failure
6.6
8.2
20
31
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
8.1
60
246
G41.0
ICD-10 Finland
Grand mal status epilepticus
33.7
8.1
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
8.1
221
1496
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
8.0
108
583
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.8
8.0
32
86
SPAT1216
SPAT
Assessment of functional ability
1.9
8.0
120
673
N02BE01
ATC
paracetamol; systemic, rectal
1.6
8.0
707
6278
B01AC04
ATC
clopidogrel; oral
2.0
7.9
109
594
H53.2
ICD-10 Finland
Diplopia
3.5
7.9
35
103
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.9
422
3345
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
5.5
7.9
22
41
A06AD11
ATC
lactulose; oral
1.9
7.8
111
610
B02.8
ICD-10 Finland
Zoster with other complications
15.2
7.7
12
8
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
7.5
7.7
17
23
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
7.5
7.7
17
23
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
7.6
50
192
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.5
213
1447
M03BX01
ATC
baclofen; systemic
4.0
7.5
28
71
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
7.5
64
283
P01BA02
ATC
hydroxychloroquine; oral
2.2
7.5
77
373
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.4
172
1111
J01FF01
ATC
clindamycin; systemic
1.6
7.3
218
1503
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.4
7.3
34
104
R47.0
ICD-10 Finland
Dysphasia and aphasia
6.9
7.3
17
25
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.0
7.3
40
138
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
7.3
7
*
B02.0
ICD-10 Finland
Zoster encephalitis
+∞
7.3
7
*
32099
ICD-8 Finland
Meningitis, With no organism specified as cause
+∞
7.3
7
*
J05AB01
ATC
aciclovir; systemic
1.7
7.3
166
1065
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
7.3
57
242
R1260
NOMESCO Finland
Evaluation of communicative skills
4.9
7.2
22
46
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
30.3
7.2
9
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
7.1
83
423
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
20.2
7.1
10
5
Z71.8
ICD-10 Finland
Other specified counselling
1.6
7.1
194
1307
A29
ICPC
General symptom/complaint other
2.0
7.1
87
453
N02AX02
ATC
tramadol; systemic, rectal
1.5
7.1
321
2438
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
7.1
76
375
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
7.1
98
534
L04AX07
ATC
dimethyl fumarate; oral
10.1
7.0
13
13
N06AA09
ATC
amitriptyline; systemic
2.1
7.0
80
404
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.1
7.0
16
23
N03AE01
ATC
clonazepam; systemic
2.4
7.0
56
241
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
7.0
37
125
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.9
6.9
18
31
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
6.9
95
515
SPAT1255
SPAT
Intravenous administration of medicine
2.3
6.9
60
268
N30.0
ICD-10 Finland
Acute cystitis
1.9
6.9
106
602
A04
ICPC
Weakness/tiredness general
1.9
6.9
106
602
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.9
89
474
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.4
6.9
57
249
N05BA04
ATC
oxazepam; oral
1.6
6.8
195
1325
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.8
6.8
41
150
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
5.4
6.8
19
36
G40
ICD-10 Finland
Epilepsy
6.2
6.8
17
28
M32
ICD-10 Finland
Systemic lupus erythematosus
40.4
6.8
8
*
WX872
NOMESCO Finland
Intensive care
2.7
6.8
44
169
N03AX23
ATC
brivaracetam; systemic
16.8
6.8
10
6
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.8
6.7
26
69
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
22.7
6.7
9
*
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
22.7
6.7
9
*
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
22.7
6.7
9
*
N03AX22
ATC
perampanel; oral
22.7
6.7
9
*
N06AX16
ATC
venlafaxine; oral
1.8
6.6
109
630
N05CD08
ATC
midazolam; nasal, systemic
3.9
6.6
25
65
C07AB07
ATC
bisoprolol; oral
1.5
6.5
325
2506
WX110
NOMESCO Finland
Local anesthesy
1.4
6.5
567
4880
C01CA24
ATC
epinephrine; parenteral
2.3
6.4
58
266
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
6.4
67
327
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
6.4
137
862
R55
ICD-10 Finland
Syncope and collapse
2.0
6.4
82
436
B01AB05
ATC
enoxaparin; parenteral
1.5
6.4
221
1573
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
6.3
59
273
N29
ICPC
Neurological sympt/complt other
4.2
6.3
22
53
B02.1
ICD-10 Finland
Zoster meningitis
+∞
6.3
6
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
6.3
6
*
3238X
ICD-9 Finland
Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]
+∞
6.3
6
*
R51
ICD-10 Finland
Headache
2.4
6.3
48
203
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.8
6.2
19
40
M31.1
ICD-10 Finland
Thrombotic microangiopathy
26.9
6.2
8
*
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.2
116
700
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.1
6.2
18
36
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.8
6.2
16
28
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.3
6.1
28
86
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
6.1
58
273
N06AX21
ATC
duloxetine; oral
1.9
6.1
87
482
G44.8
ICD-10 Finland
Other specified headache syndromes
6.1
6.0
15
25
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
6.0
40
157

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044290) Cell count panel - Cerebral spinal fluid
293
155
26.28
307.65
1.7
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
331
188
25.77
307.65
1.7
1.3
mg/l
677.0
449.6
8.09
324
177
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
215
44
61.91
307.65
1.3
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
285
172
22.74
307.65
1.8
1.5
e6/l
661.6
814.3
0.08
225
139
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
285
172
22.74
307.65
1.7
1.4
e6/l
51.7
8.5
4.23
218
134
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
233
86
34.98
307.65
1.2
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
220
40
70.15
307.65
1.3
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
213
66
40.69
307.65
1.4
1.9
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
326
167
28.43
307.65
1.6
1.2
mmol/l
3.6
3.8
1.28
311
158
(3016018) Differential panel - Cerebral spinal fluid
201
72
34.65
306.25
1.6
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
200
72
34.44
304.19
1.2
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
157
35
52.99
270.90
1.5
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
149
30
58.15
262.51
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
181
85
25.76
248.95
1.8
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
131
49
30.60
194.88
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
109
21
58.10
192.74
1.3
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
138
63
25.24
190.83
1.4
1.1
mg/l
58.2
40.5
1.54
122
49
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
106
22
53.75
184.53
1.3
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
105
21
55.72
184.18
1.3
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
132
59
25.61
183.92
1.3
1.1
mg/l
341.2
232.7
3.12
122
53
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
105
23
50.87
180.65
1.3
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
108
30
40.22
175.39
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
128
60
24.30
174.87
1.3
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
150
105
16.62
169.84
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
90
13
75.95
166.90
1.2
1.1
—
—
—
0
0
(4027681)
120
55
24.64
165.25
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
97
23
46.58
163.70
1.3
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
283
547
6.81
148.25
2.7
2.3
au/ml
22.6
20.0
—
6
30
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
263
490
6.92
142.51
1.5
1.3
au/ml
44.8
31.8
—
5
27
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
100
50
22.10
132.41
1.5
1.0
u/l
1.1
1.1
0.05
49
30
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
68
17
42.83
112.75
1.2
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
263
619
5.40
109.06
3.4
2.5
g/l
9.8
10.6
1.91
243
568
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
160
232
8.01
108.06
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
64
16
42.66
106.03
1.3
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
74
31
25.69
104.77
1.1
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
99
88
12.37
96.36
1.5
1.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
51
11
48.79
87.18
1.4
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
52
13
42.13
85.91
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
51
13
41.28
83.83
1.2
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
50
12
43.80
83.39
1.2
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
63
36
18.60
78.03
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
79
72
11.82
75.38
3.2
2.1
e9/l
1.3
1.1
1.20
48
40
(3014148) Varicella zoster virus Ab [Titer] in Serum
88
97
9.85
73.52
1.2
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
65
49
14.11
69.60
3.2
2.2
e9/l
0.2
0.2
1.17
59
41
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
66
52
13.52
68.87
3.2
2.1
e6/l
523.0
494.3
0.12
59
42
(3023368) Bacteria identified in Blood by Culture
449
2045
3.16
68.27
5.6
4.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
62
54
12.17
60.75
2.9
1.9
%
14.1
11.3
0.63
38
25
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
63
57
11.73
60.23
2.7
2.1
e6/l
709.6
670.2
0.12
25
23
(3018677) aPTT in Platelet poor plasma by Coagulation assay
299
1167
3.22
57.73
2.8
2.3
s
28.9
29.7
2.28
293
1132
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
306
1218
3.18
57.05
2.0
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
459
2292
2.85
56.55
3.0
2.1
u/l
217.1
270.8
0.36
446
2162
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
57
50
12.03
55.54
2.9
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
60
7
91.13
54.52
1.5
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
63
66
10.12
54.42
2.9
2.0
%
49.0
39.7
—
10
7
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
67
77
9.25
54.03
1.6
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
497
2645
2.74
53.26
9.8
6.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
574
3359
2.66
49.66
9.1
6.4
mmol/l
1.2
1.2
2.36
529
3058
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
46
34
14.13
49.62
1.5
1.0
miu/ml
1596.3
1558.3
0.05
46
34
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
50
44
11.91
48.55
1.2
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
553
3203
2.62
48.48
6.2
4.9
g/l
34.8
35.9
3.56
524
2981
(3000060) B lymphocytes [#/volume] in Blood
39
22
18.40
48.31
2.7
2.0
e6/l
184.2
271.1
—
24
9
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
112
248
4.96
48.08
4.8
1.5
g/l
0.2
0.2
3.26
104
240
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
231
859
3.19
47.45
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
230
855
3.19
47.25
2.0
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
113
259
4.79
46.51
4.9
1.5
g/l
1.1
1.2
2.37
105
249
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
606
3730
2.58
45.81
9.9
7.0
mmol/l
1.2
1.2
0.65
516
3163
(3001604) Monocytes [#/volume] in Blood
634
3994
2.59
45.50
9.9
5.9
e9/l
0.6
0.6
1.68
563
3474
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
51
7
76.46
45.41
1.4
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
597
3663
2.55
45.21
10.1
6.1
%
0.6
0.7
0.43
572
3431
(3006315) Basophils [#/volume] in Blood
634
4012
2.57
44.77
9.9
6.0
e9/l
0.0
0.0
0.03
562
3493
(3013826) Glucose [Moles/volume] in Serum or Plasma
688
4544
2.63
44.08
7.6
5.0
mmol/l
6.6
6.7
0.07
660
4218
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
51
9
59.58
43.80
1.4
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
604
3771
2.51
43.36
10.2
6.1
%
2.5
2.8
3.18
580
3527
(3019069) Monocytes/100 leukocytes in Blood
605
3793
2.50
42.83
10.5
6.3
%
8.8
8.5
1.01
582
3572
(3019198) Lymphocytes [#/volume] in Blood
641
4129
2.53
42.73
9.9
6.0
e9/l
1.8
2.0
2.28
574
3656
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
102
236
4.70
41.40
1.3
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
640
4158
2.49
41.26
10.8
6.3
e9/l
0.2
0.2
1.53
572
3672
(3023183) Ammonium ion [Moles/volume] in Plasma
90
188
5.16
41.23
3.2
3.6
umol/l
27.9
35.3
3.10
78
161
(3002030) Lymphocytes/100 leukocytes in Blood
612
3908
2.45
40.83
10.3
6.1
%
26.4
28.3
4.20
588
3666
(3033658) Prothrombin time (PT) actual/Normal
376
1944
2.49
40.07
5.3
4.0
%
90.2
91.6
0.52
368
1894
(3018010) Neutrophils/100 leukocytes in Blood
604
3858
2.42
39.91
9.9
5.9
%
58.5
57.0
2.37
583
3636
(36304419) Bacteria [Presence] in Urine
393
2082
2.46
39.61
4.4
3.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
152
496
3.43
38.14
2.4
1.7
g/l
1.1
1.4
1.10
136
460
(3030467) Casts [#/volume] in Urine by Automated count
395
2126
2.41
38.13
4.5
3.1
e6/l
0.3
0.4
1.68
313
1596
(3013650) Neutrophils [#/volume] in Blood by Automated count
676
4644
2.39
36.28
13.8
9.1
e9/l
4.2
4.1
0.95
603
4072
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
26
11
24.24
36.12
1.4
5.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
400
2207
2.35
36.04
5.2
3.9
ph
7.4
7.4
1.29
64
425
(3002582) Erythrocytes [#/volume] in Urine
416
2342
2.33
35.68
4.5
3.2
e6/l
29.0
86.1
1.23
332
1798
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
41
7
60.96
35.43
1.3
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
493
2994
2.27
35.11
8.6
9.0
inr
1.2
1.2
0.31
128
916
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
70
136
5.46
34.70
1.3
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
77
163
5.03
34.66
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
77
163
5.03
34.66
1.3
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
464
2768
2.26
34.28
5.4
3.7
e6/l
36.7
97.7
2.57
351
1934
(3003458) Phosphate [Moles/volume] in Serum or Plasma
229
999
2.67
34.07
7.9
5.9
mmol/l
1.0
1.1
0.39
211
925
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
24
10
24.56
33.48
1.5
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
156
559
3.12
33.37
2.4
2.8
g/l
66.0
66.7
0.43
140
514
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
116
354
3.57
32.10
2.0
2.0
u/l
33.4
38.4
2.14
107
320
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
98
269
3.93
31.64
5.7
2.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
37
7
54.78
31.49
1.6
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
262
1269
2.44
30.98
3.9
2.8
e6/l
0.9
1.0
0.63
151
711
(46235355) HIV 1 and 2 tests - Meaningful Use set
328
1755
2.29
30.83
1.7
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
737
5470
2.31
29.83
7.0
4.1
—
—
—
0
0
(3026782) Osmolality of Urine
293
1525
2.30
29.16
3.8
2.8
mosm/kgh2o
547.9
560.1
0.42
250
1310
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
33
5
68.09
29.07
1.1
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
707
5185
2.23
29.06
6.6
4.2
e6/l
388.0
1486.9
—
7
80
(3004588) Protein electrophoresis panel - Serum or Plasma
132
464
3.12
29.01
2.1
2.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
250
1219
2.40
28.89
4.7
3.8
mmol/l
0.8
0.8
0.54
224
1149
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
88
239
3.94
28.79
2.2
2.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
33
6
56.77
28.30
1.1
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
300
1611
2.23
27.44
3.2
2.6
e6/l
4.7
6.5
1.79
271
1423
(3027135) IgG subclass 1 [Mass/volume] in Serum
45
72
6.50
27.17
1.3
1.3
g/l
6.7
7.7
0.53
34
50
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
244
1206
2.35
27.16
4.1
2.9
e6/l
3.1
2.6
0.21
133
650
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
31
5
63.88
27.09
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
348
1998
2.14
26.76
9.9
6.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
185
811
2.57
26.73
4.7
4.5
u/l
285.2
254.1
0.42
172
766
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
246
3.73
26.10
2.0
2.6
g/l
10.7
10.5
0.13
66
213
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
72
6.35
25.99
1.3
1.3
g/l
3.0
2.8
0.17
33
49
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
72
6.35
25.99
1.3
1.3
g/l
0.3
0.4
0.71
33
49
(3036481) Cortisol [Moles/volume] in Serum or Plasma
173
747
2.59
25.73
2.5
2.1
nmol/l
354.0
369.8
0.54
163
693
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
121
434
3.03
25.58
1.8
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
577
4035
2.01
25.31
7.3
6.3
umol/l
10.5
12.0
2.98
550
3815
(4062490)
44
74
6.17
25.30
1.3
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
769
6027
2.18
23.93
10.6
7.4
u/l
77.1
78.8
0.56
736
5672
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
82
5.70
23.84
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
30
35
8.80
23.74
1.4
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
29
7
42.55
23.71
1.4
4.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
260
1388
2.18
23.65
3.7
3.7
ng/l
100.8
398.5
3.23
196
1032
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
77
219
3.72
23.54
1.9
2.2
mg/l
11.5
11.1
0.17
68
203
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
265
3.46
23.31
2.0
2.6
g/l
7.2
7.4
0.60
60
206
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
265
3.46
23.31
2.0
2.6
g/l
3.9
3.7
0.30
59
196
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
265
3.46
23.31
2.0
2.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
29
8
37.27
23.09
1.4
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
451
2961
1.95
23.05
2.3
1.9
pmol/l
91.0
94.7
0.88
253
1557
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
74
208
3.76
23.01
1.8
2.8
g/l
36.9
38.0
0.57
58
183
(3020779) Urea [Moles/volume] in Serum or Plasma
152
650
2.58
22.92
7.9
8.1
mmol/l
8.3
9.1
0.78
144
620
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
25
24
10.66
22.74
3.6
2.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
58
140
4.34
22.18
1.5
1.3
u/ml
3.3
5.9
0.73
36
57
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
68
185
3.87
22.14
1.9
3.0
g/l
0.0
0.0
0.00
57
174
(3024980) IgG subclass 4 [Mass/volume] in Serum
54
124
4.55
21.99
1.4
1.8
g/l
0.4
0.9
2.40
43
94
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
250
3.44
21.89
2.0
2.6
g/l
3.1
3.1
0.09
61
200
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
68
187
3.83
21.81
1.9
3.0
g/l
0.0
0.0
0.00
57
175
(3019309) Folate [Moles/volume] in Red Blood Cells
246
1328
2.13
21.51
1.8
1.7
nmol/l
998.1
1173.4
2.62
192
1002
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
85
274
3.30
21.44
1.8
1.6
iu/ml
0.2
0.1
0.24
21
50
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
70
200
3.69
21.25
1.9
2.9
g/l
0.1
0.0
0.19
59
188
(3000991) Gas panel - Venous blood
148
650
2.50
21.02
10.2
9.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
84
274
3.25
20.78
2.0
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
27
9
30.78
20.63
1.1
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
27
9
30.78
20.63
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
92
319
3.07
20.54
2.9
2.5
s
22.4
21.3
0.43
85
291
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
6
42.62
20.52
1.3
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
64
177
3.79
20.36
5.3
5.9
iu/ml
266.1
352.5
—
8
25
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
33
52
6.53
20.19
3.5
2.6
%
43.2
42.3
0.05
15
14
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
104
390
2.86
20.19
5.2
4.7
mmol/l
23.3
24.0
1.27
95
355
(3026008) Bacteria identified in Urine by Culture
362
2284
1.91
20.18
4.1
2.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
52
126
4.30
19.78
1.4
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
73
225
3.42
19.76
1.9
2.9
g/l
1.7
0.8
0.51
59
202
(3002032) Base excess in Venous blood by calculation
155
721
2.36
19.32
4.7
4.1
mmol/l
1.6
1.8
0.37
129
572
(3021589) Normoblasts [#/volume] in Blood
505
3577
1.83
19.24
13.5
9.2
e9/l
0.0
0.0
0.53
412
2931
(3014111) Lactate [Moles/volume] in Serum or Plasma
151
696
2.38
19.21
9.0
7.7
mmol/l
1.4
1.4
0.19
139
661
(3009466) Valproate [Moles/volume] in Serum or Plasma
51
126
4.21
18.92
4.1
5.9
umol/l
324.5
380.6
2.18
44
108
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
23
6
39.20
18.61
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
53
138
4.00
18.34
1.5
1.2
u/ml
4.4
5.2
0.10
22
44
(21494814) CD8 cells/100 lymphocytes in Specimen
23
27
8.69
18.07
2.7
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
208
1120
2.08
17.98
1.8
1.3
titre
389.1
477.2
0.67
66
241
(3003396) Base excess in Arterial blood by calculation
167
830
2.21
17.72
10.6
8.9
mmol/l
1.4
1.0
0.49
130
651
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
167
837
2.19
17.33
10.6
8.8
kpa
5.1
5.1
0.06
154
803
(3017143) Hepatitis C virus Ab [Presence] in Serum
194
1031
2.09
17.32
1.7
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
167
838
2.19
17.28
10.6
8.8
kpa
12.0
12.4
0.34
154
807
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
79
279
2.99
17.06
3.2
2.7
%
98.4
91.1
1.57
73
264
(3013707) Erythrocyte sedimentation rate by Westergren method
724
5842
1.86
16.85
6.1
4.0
mm/h
13.4
11.3
3.13
687
5417
(3006653) Thiamine [Moles/volume] in Blood
26
39
6.82
16.64
1.2
1.3
nmol/l
123.9
159.0
2.34
26
39
(3024891) Influenza virus A+B Ag [Presence] in Specimen
73
250
3.07
16.62
1.2
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
390
2639
1.78
16.60
4.5
3.3
u/l
44.3
32.3
0.65
365
2519
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
62
193
3.36
16.52
1.5
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
38
83
4.72
16.45
1.2
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
133
621
2.32
16.33
3.9
3.6
kpa
4.9
4.6
0.87
127
603
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
84
318
2.79
15.98
2.5
2.1
g/l
1.7
1.4
1.32
70
278
(3015377) Calcium [Moles/volume] in Serum or Plasma
376
2547
1.76
15.75
3.8
3.3
mmol/l
2.3
2.4
1.79
330
2252
(3011397) Hemoglobin [Presence] in Urine by Test strip
283
1766
1.84
15.60
4.6
3.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
20
24
8.48
15.42
1.3
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
448
3210
1.71
15.20
2.7
2.3
nmol/l
75.2
75.7
0.13
409
2903
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
51
148
3.58
15.13
1.2
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
286
1819
1.80
14.67
2.1
1.9
mg/l
1.0
1.2
0.36
226
1364
(3003181) Sodium [Moles/volume] in Urine
44
118
3.85
14.63
1.3
1.4
mmol/l
65.5
64.7
0.04
36
102
(3007853) Bacteria identified in Skin by Aerobe culture
174
944
2.02
14.51
2.2
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
56
178
3.27
14.44
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
60
199
3.14
14.43
1.5
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
304
1977
1.77
14.42
2.4
2.2
mg/l
3.1
3.0
0.36
257
1679
(3027945) Reticulocytes/100 erythrocytes in Blood
158
833
2.06
14.23
2.9
2.8
%
1.8
1.8
0.00
137
759
(3007164) IgA [Mass/volume] in Serum or Plasma
266
1683
1.79
13.76
2.1
1.4
g/l
2.1
2.4
1.73
194
1039
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
673
5483
1.69
13.27
4.3
3.2
u/l
52.0
46.5
1.10
634
5163
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
142
3.42
13.14
1.6
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
113
541
2.23
12.99
1.8
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
18
9.02
12.91
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
132
674
2.10
12.90
1.6
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
142
747
2.05
12.81
11.5
9.4
%
95.6
95.8
0.10
137
720
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
906
8104
2.21
12.80
25.9
13.4
mg/l
22.8
23.1
0.13
793
6358
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
23
40
5.86
12.77
1.0
1.0
ng/l
408.3
238.4
0.98
18
22
(4268621)
36
94
3.94
12.44
2.8
2.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
136
712
2.05
12.42
2.3
2.4
u/l
39.7
36.4
0.11
122
598
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
24
45
5.44
12.34
1.2
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
72
288
2.62
12.31
2.5
2.2
ug/l
0.7
2.4
0.94
65
255
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
43
129
3.44
12.16
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
61
226
2.81
12.09
1.8
1.2
u/ml
36.9
2.0
—
5
8
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
55
193
2.96
12.03
1.2
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
398
2890
1.62
12.02
4.6
3.5
ng/l
43.2
41.3
0.06
281
1904
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
29
66
4.49
11.97
1.1
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
23
7.50
11.87
1.5
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
35
93
3.86
11.81
1.2
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
22
40
5.60
11.68
1.0
1.0
ng/l
43.4
33.3
0.60
16
21
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
22
40
5.60
11.68
1.0
1.0
ng/l
618.8
586.6
0.12
16
23
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
50
169
3.06
11.67
1.3
1.4
u/ml
90.6
100.8
—
8
34
(44790049)
36
99
3.73
11.58
1.7
1.6
—
—
—
0
0
(44806118)
36
99
3.73
11.58
1.7
1.6
—
—
—
0
0
(44790048)
36
99
3.73
11.58
1.7
1.6
—
—
—
0
0
(44790047)
36
99
3.73
11.58
1.7
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
167
962
1.88
11.52
1.4
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
100
3.70
11.42
1.3
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
509
3962
1.58
11.23
5.4
3.5
estimate
0.0
0.0
0.80
96
737
(3019550) Sodium [Moles/volume] in Serum or Plasma
902
8134
2.07
11.19
27.8
15.1
mmol/l
139.1
139.6
7.17
891
7918
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
49
168
3.02
11.17
1.7
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
503
3910
1.57
11.12
7.6
4.8
estimate
0.0
0.0
0.50
98
765
(3035350) Ketones [Presence] in Urine by Test strip
503
3911
1.57
11.10
5.4
3.4
estimate
0.0
0.0
0.00
94
750
(3042936) Bacteria identified in Isolate by Culture
183
1098
1.82
11.06
2.5
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
22
7.37
11.01
2.8
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
143
3.17
10.98
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
103
510
2.14
10.87
1.5
1.3
u/ml
125.6
227.1
1.16
96
465
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
133
728
1.95
10.67
2.9
2.5
g/l
0.2
0.2
1.18
119
688
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
339
2423
1.60
10.62
3.0
2.5
u/l
57.6
57.0
0.10
320
2265
(3023520) Reticulocytes [#/volume] in Blood
116
607
2.03
10.56
2.9
3.0
e9/l
67.6
71.7
0.57
84
472
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
101
3.55
10.51
2.4
2.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
101
3.55
10.51
1.2
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
24
52
4.70
10.51
1.3
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
901
8159
2.02
10.47
27.9
15.2
mmol/l
3.9
4.0
0.83
886
7932
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
10
0
+∞
10.43
1.1
0.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
256
1720
1.66
10.24
1.7
1.5
nmol/l
18.5
20.3
1.69
238
1471
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
55
211
2.70
10.23
1.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
221
1430
1.70
10.20
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
342
2469
1.58
10.19
2.8
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
18
7.87
10.16
1.5
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
44
150
3.02
10.14
3.0
4.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
51
190
2.77
10.03
1.2
1.4
u/ml
304.0
239.3
0.50
32
116
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
83
391
2.22
9.91
12.2
11.0
mmol/l
24.4
24.4
0.00
73
371
(3001186) Copper [Moles/volume] in Serum or Plasma
12
13
9.33
9.88
1.4
1.1
umol/l
16.4
18.6
0.63
12
13
(3008295) Osmolality of Serum or Plasma
31
86
3.69
9.87
1.4
1.5
mosm/kgh2o
280.2
282.9
0.17
22
61
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
823
7296
1.71
9.62
5.5
4.6
mu/l
1.8
2.0
0.85
771
6725
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
37
118
3.22
9.54
1.1
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
54
213
2.62
9.52
1.9
1.2
u/ml
17.5
2.7
—
10
23
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
54
214
2.61
9.44
1.9
1.2
u/ml
5.4
10.8
0.41
12
33
(3009343) pH of Capillary blood
100
524
2.01
9.06
4.6
4.4
ph
7.4
7.4
—
10
64
(3000093) Morphology [Interpretation] in Blood Narrative
26
68
3.90
9.00
1.7
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
88
441
2.09
9.00
10.5
8.5
mmol/l
25.2
24.3
1.48
82
413
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
208
2.58
8.93
3.3
3.8
mg/l
92.9
32.9
0.57
46
166
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
208
2.58
8.93
3.3
3.8
mg/l
34.3
79.7
0.83
45
166
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
173
2.74
8.91
1.5
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
104
557
1.97
8.86
4.0
4.1
ng/l
80.3
80.5
0.01
87
499
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
100
530
1.98
8.78
4.6
4.4
kpa
5.3
5.1
1.18
93
497
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
96
502
2.01
8.75
4.5
4.5
mmol/l
1.7
1.6
0.14
76
371
(3019060) Gas panel - Arterial blood
91
469
2.03
8.63
8.0
6.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
704
6076
1.53
8.50
4.6
3.9
pmol/l
14.8
14.7
0.78
660
5553
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
226
2.47
8.45
3.4
3.4
u/ml
0.3
0.3
0.13
29
129
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
45
174
2.66
8.28
1.9
1.2
u/ml
35.0
40.4
—
6
13
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
118
3.04
8.26
1.7
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
78
388
2.10
8.14
14.3
12.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
50
206
2.50
8.10
3.4
3.7
ratio
1.5
2.0
—
5
20
(3004789) Transferrin [Mass/volume] in Serum or Plasma
172
1107
1.67
7.95
3.0
2.4
g/l
2.3
2.3
0.10
161
1023
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
198
1322
1.62
7.92
3.5
2.9
mmol/l
2.4
2.4
0.36
168
1170
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
95
3.22
7.86
1.6
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
115
666
1.82
7.71
5.2
4.5
%
0.9
0.9
0.02
51
206
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
175
2.58
7.67
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
63
295
2.21
7.67
1.9
1.9
—
—
—
0
0
(4035726)
110
630
1.84
7.64
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
161
1029
1.67
7.63
3.1
2.4
%
18.4
23.3
5.76
132
887
(3022313) Gas panel - Capillary blood
76
385
2.05
7.57
4.7
4.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
107
610
1.84
7.55
4.8
4.4
%
0.6
0.5
0.13
42
153
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
457
3676
1.45
7.48
4.6
4.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
37
138
2.75
7.32
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
282
2.20
7.25
4.3
3.7
g/l
0.2
0.3
1.49
34
126
(3037756) Immunofixation for Serum or Plasma
38
145
2.68
7.20
1.3
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
41
163
2.58
7.17
5.8
4.1
mmol/l
2.8
2.3
0.61
29
108
(3022948) Iron [Moles/volume] in Serum or Plasma
179
1193
1.61
7.17
3.0
2.4
umol/l
11.5
13.3
2.73
166
1099
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
70
3.49
7.15
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
70
3.49
7.15
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
70
3.49
7.15
1.4
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
41
164
2.56
7.08
5.1
4.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
71
3.44
7.00
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
71
3.44
7.00
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
71
3.44
7.00
1.4
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
260
1896
1.50
6.94
2.7
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
150
964
1.65
6.94
1.5
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
64
316
2.10
6.84
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
107
630
1.78
6.79
5.4
4.6
%
0.2
0.1
0.43
49
188
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
60
290
2.14
6.77
1.3
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
224
3035
0.66
6.72
2.7
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
124
764
1.71
6.72
4.4
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
275
2042
1.48
6.68
3.1
3.2
ng/l
1101.7
1323.6
0.77
226
1721
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
45
4.05
6.64
1.5
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
209
2.31
6.49
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
45
197
2.34
6.44
5.7
3.9
ph
7.4
7.4
0.07
40
161
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
97
564
1.80
6.42
2.4
3.0
ng/l
190.6
207.4
0.11
88
507
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
85
476
1.86
6.35
1.8
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
34
131
2.65
6.35
1.4
1.1
iu/ml
43397.7
77.6
—
6
30
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
93
2.96
6.19
3.3
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
439
3591
1.40
6.15
3.3
2.7
ug/l
136.5
115.3
0.70
401
3334
(3025159) Blasts/100 leukocytes in Blood
100
595
1.76
6.13
5.1
4.7
%
0.0
0.1
1.03
43
162
(3026493) Urate [Moles/volume] in Serum or Plasma
264
1975
1.46
6.10
3.4
2.7
umol/l
1734.0
5778.9
1.65
232
1715
(4198724)
15
35
4.34
6.04
1.5
1.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
16
6.30
5.96
3.6
2.1
umol/l
16.2
14.8
—
10
16
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
137
894
1.62
5.94
3.3
3.1
umol/l
7.9
8.7
0.23
114
767
(40761535) Cells panel - Urine sediment
103
624
1.73
5.93
4.3
3.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
16
40
4.05
5.91
10.4
7.5
u/ml
6688.7
46.5
—
7
13
(3035637) Corticotropin [Mass/volume] in Plasma
25
85
2.99
5.87
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
71
3.15
5.64
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
71
3.15
5.64
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
71
3.15
5.64
1.2
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
47
224
2.15
5.54
4.0
3.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
21
5.29
5.53
2.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
813
7467
1.47
5.31
21.4
12.0
ml/min/173m2
85.9
84.4
0.96
701
6097
(3022217) INR in Platelet poor plasma by Coagulation assay
134
897
1.57
5.22
28.7
20.9
inr
1.2
1.3
0.16
14
127
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
20
64
3.17
5.21
1.2
1.1
nmol/l
0.1
1.3
—
5
12
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
909
8562
1.65
5.17
16.4
9.9
u/l
27.9
26.8
1.05
884
8291
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
45
3.60
5.06
1.1
1.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
45
3.60
5.06
1.1
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
902
8495
1.61
4.94
21.3
12.4
—
—
—
0
0
(4306422)
30
125
2.44
4.84
1.2
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
7
11.51
4.79
1.4
6.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
252
1.99
4.76
1.9
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
635
5649
1.34
4.62
3.4
3.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
48
3.37
4.62
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
607
5367
1.33
4.60
3.9
3.6
—
—
—
0
0
(4010399)
85
533
1.65
4.34
1.3
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
45
3.37
4.33
1.1
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
6
11.74
4.28
1.0
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
12
31
3.91
4.26
3.1
3.2
umol/l
28.6
35.6
—
7
24
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
23
4.38
4.09
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
151
1091
1.45
4.09
1.7
1.8
%
1.5
1.5
0.67
128
970
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
94
616
1.58
4.03
2.4
2.5
ug/l
4.6
7.9
2.40
77
547
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
30
138
2.21
3.92
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
208
1602
1.38
3.91
1.6
1.7
pmol/l
36842534.1
31343710.0
0.05
190
1340
(1616796) Gas panel - Central venous blood
34
165
2.10
3.90
5.7
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
83
535
1.60
3.82
2.8
2.6
e9/l
4.2
4.1
0.10
63
432
(3004616) Nuclear Ab [Presence] in Serum
22
89
2.50
3.81
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
29
3.82
3.81
1.4
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
34
3.56
3.77
1.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
5
12.06
3.76
1.2
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
258
2067
1.33
3.75
3.9
3.3
mg/l
1042.9
331.9
0.82
179
1345
(3002385) Erythrocyte distribution width [Ratio]
744
6863
1.32
3.69
30.7
16.2
%
13.8
13.6
2.70
735
6727
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
12
6.71
3.68
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
16
5.67
3.66
1.1
1.4
—
—
—
0
0
(3020891) Body temperature
50
285
1.79
3.63
6.7
4.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
36
184
1.99
3.62
4.2
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
89
592
1.55
3.60
1.3
1.2
iu/ml
199.6
156.1
0.35
32
240
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
41
3.20
3.50
1.4
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
41
3.20
3.50
1.4
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
89
596
1.54
3.50
6.3
3.7
mmol/l
1.2
1.2
1.64
79
525
(3009508) Creatinine [Moles/volume] in Urine
284
2331
1.30
3.44
4.3
3.2
mmol/l
7.7
7.9
0.30
239
1977
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
177
1360
1.37
3.36
1.4
1.3
iu/ml
18.9
29.6
1.45
49
424
(3024932) HLA-DR beta [Type]
10
27
3.73
3.36
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
14
5.75
3.34
1.6
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
32
3.46
3.34
1.1
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
32
3.46
3.34
1.1
2.1
—
—
—
0
0
(3019225) pH of Specimen
103
719
1.48
3.34
6.2
4.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
102
2.28
3.31
3.4
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
364
3101
1.27
3.27
2.0
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
267
2189
1.30
3.24
4.9
4.0
mg/mmol
12.4
9.7
0.43
183
1410
(3024471) HLA-A [Type]
10
28
3.60
3.20
1.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
33
3.36
3.20
1.1
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
58
359
1.65
3.17
2.0
2.3
u/l
1960.8
3670.7
0.62
17
157
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
79
2.43
3.15
1.1
1.2
u/l
54.8
61.4
0.16
12
55
(3009542) Hematocrit [Volume Fraction] of Blood
808
7598
1.32
3.11
27.5
14.2
%
39.3
40.2
2.32
598
5726
(21494755) Public health laboratory ask at order entry panel
60
921
0.63
3.07
1.3
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
160
1.97
3.07
4.4
3.6
e9/l
4.0
4.2
0.24
31
160
(3051611) Lipemic interference index of Serum or Plasma
18
74
2.46
3.06
3.7
3.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
62
2.61
3.05
1.1
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
62
2.61
3.05
1.6
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
650
1.47
3.01
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
9
6.70
2.87
3.8
3.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
41
2.95
2.86
1.1
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
41
2.95
2.86
1.1
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
41
2.95
2.86
1.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
41
2.95
2.86
1.1
1.9
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
13
47
2.79
2.82
1.1
1.1
ratio
1.0
1.1
—
7
19
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
85
592
1.48
2.81
2.9
2.4
ml/min/173m2
78.5
68.2
0.28
37
238
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
166
1.90
2.79
5.0
3.9
%
57.5
56.5
0.17
31
166
(40767503) Oxygen content in Capillary blood by calculation
31
166
1.90
2.79
3.0
2.2
%
16.9
16.5
0.17
14
85
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
73
496
1.51
2.73
3.3
3.5
pmol/l
4.3
4.6
1.49
62
439
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
14
5.03
2.73
2.6
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
66
2.45
2.72
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
71
481
1.51
2.69
4.6
2.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
140
1.95
2.67
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
73
2.35
2.66
2.6
2.9
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
15
4.69
2.60
1.0
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
17
74
2.32
2.59
1.5
1.4
mmol/l
11.2
12.3
—
10
16
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
121
2.01
2.57
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
20
4.02
2.57
1.3
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
88
2.18
2.52
1.2
1.4
pmol/l
301.9
363.9
0.29
12
69
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
26
3.48
2.48
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
39
2.84
2.48
1.1
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
63
2.40
2.47
1.1
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
21
3.83
2.46
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
57
2.48
2.45
3.9
3.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
51
2.57
2.45
1.8
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
124
1.96
2.42
2.7
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
40
2.77
2.38
1.1
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
84
2.16
2.36
3.3
2.5
mg/l
18.5
21.8
—
6
23
(3003338) MCHC [Mass/volume]
748
7045
1.24
2.34
31.3
16.8
g/l
333.0
333.0
0.02
741
6999
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
47
302
1.58
2.29
1.3
1.3
miu/ml
211.6
246.8
0.22
19
144
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
13
4.64
2.27
1.2
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
29
3.12
2.23
2.8
3.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
10
36
2.80
2.20
1.9
5.6
mg/l
72.4
66.4
—
10
26
(40768443) Skin Pathology biopsy report
47
305
1.57
2.20
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
247
2096
1.24
2.18
6.0
3.7
estimate
0.0
0.0
1.08
93
747
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
74
2.18
2.15
3.8
3.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
209
1743
1.25
2.15
6.1
3.6
kg/l
1.0
1.0
0.25
37
236
(3045142) Bone marrow Pathology biopsy report
17
81
2.12
2.13
1.4
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
85
626
1.39
2.13
2.1
2.2
nmol/l
13.1
13.1
0.00
76
567
(3021901) Oxygen saturation in Capillary blood
26
145
1.81
2.12
3.0
2.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
756
7155
1.23
2.12
6.4
5.4
mmol/mol
40.0
39.5
0.62
705
6677
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
225
1900
1.24
2.07
1.3
1.3
u/ml
2.9
1.5
0.28
43
512
(3045788) Cell count panel - Pleural fluid
13
56
2.34
2.05
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
36
560
0.63
2.02
1.3
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
26
3.09
2.01
6.3
3.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
32
2.83
2.00
3.2
2.6
ug/l
40.6
93.1
—
9
32
(3025941) Bacteria identified in Stool by Culture
64
456
1.43
1.95
1.4
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
11
4.56
1.94
1.2
1.7
—
—
—
0
0
(4211845)
9
33
2.74
1.93
2.6
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
220
1867
1.23
1.93
7.1
4.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
22
3.20
1.88
1.1
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
28
2.87
1.86
2.5
2.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
39
254
1.56
1.84
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
39
254
1.56
1.84
1.2
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
17
3.54
1.84
1.2
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
47
320
1.49
1.82
2.2
1.8
—
—
—
0
0
(4024509)
12
53
2.28
1.81
1.8
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
11
47
2.36
1.78
1.4
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
16
81
1.99
1.75
1.8
1.9
nmol/l
17.4
21.1
1.40
16
76
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
170
1.67
1.75
2.2
2.0
g/l
127.9
130.1
0.15
17
129
(42529406) Shigella sp [Presence] in Stool by Culture
39
258
1.53
1.73
1.3
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
13
3.86
1.71
1.2
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
179
1.64
1.71
1.4
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
932
9094
1.35
1.66
35.6
19.5
e9/l
7.0
6.7
3.13
912
8854
(3023511) Choriogonadotropin [Units/volume] in Urine
31
197
1.59
1.64
1.7
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
931
9085
1.34
1.64
35.6
19.5
e9/l
256.3
251.6
1.21
915
8866
(3025130) Human papilloma virus identified in Specimen
19
105
1.83
1.63
2.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
341
3058
1.17
1.62
6.0
3.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
931
9088
1.34
1.61
35.5
19.4
fl
91.0
90.6
1.76
919
8967
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
43
2.34
1.60
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
43
2.34
1.60
1.6
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
931
9089
1.33
1.60
35.4
19.4
pg
30.3
30.2
1.06
918
8967
(3026361) Erythrocytes [#/volume] in Blood
931
9090
1.33
1.59
35.6
19.5
e12/l
4.4
4.5
9.89
909
8853
(3003327) Ova and parasites identified in Stool by Light microscopy
40
272
1.49
1.58
1.8
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
64
2.04
1.54
1.0
1.2
u/ml
0.2
0.4
—
5
26
(3000963) Hemoglobin [Mass/volume] in Blood
931
9095
1.33
1.53
35.8
19.6
g/l
132.7
136.1
9.65
918
8968
(3052592) Norovirus Ag [Presence] in Stool
5
15
3.34
1.52
2.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
62
816
0.74
1.47
1.6
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
16
3.14
1.44
1.4
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
16
3.14
1.44
3.0
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
39
2.32
1.43
1.2
1.1
u/l
416.2
496.2
—
9
34
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
131
1088
1.23
1.42
1.9
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
40
2.26
1.40
2.8
2.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
67
1.95
1.38
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
142
1194
1.22
1.38
2.1
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
136
1.63
1.33
1.1
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
34
2.36
1.29
2.9
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
35
2.30
1.27
1.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
107
883
1.24
1.25
9.7
6.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
23
349
0.65
1.23
1.2
1.8
mg/l
3.4
3.1
0.10
15
244
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
44
322
1.38
1.23
1.1
1.1
—
0.9
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
45
2.01
1.23
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
212
0.56
1.19
1.5
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
38
2.11
1.18
1.4
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
33
0.00
1.16
0.0
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
33
0.00
1.16
0.0
6.1
—
—
—
0
0
(44806420)
5
20
2.51
1.15
2.8
2.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
95
1.70
1.14
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
44
328
1.36
1.12
3.7
1.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
11
58
1.91
1.12
1.9
2.3
—
1.7
—
0
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
372
1.33
1.11
2.9
2.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
31
2.27
1.10
1.0
1.0
%
100.1
122.9
—
7
31
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
218
1.44
1.10
1.7
1.4
ug/g
268.1
317.2
0.44
17
123
(3014051) Protein [Presence] in Urine by Test strip
24
160
1.51
1.10
2.3
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
124
1055
1.20
1.10
2.5
2.5
ug/g
212.6
126.8
0.69
101
846
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
104
1.65
1.10
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
104
1.65
1.10
1.3
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
211
1.43
1.07
1.9
1.9
iu/l
8.7
5.8
0.59
11
72
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
105
1.63
1.06
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
105
1.63
1.06
1.3
1.5
—
—
—
0
0
(3036603) Volume of Urine
10
52
1.93
1.06
1.4
1.5
—
1787.8
—
0
8
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
188
1.45
1.02
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
369
1.32
1.02
6.1
3.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
36
265
1.37
1.01
1.6
1.4
u/l
10.9
9.3
0.28
30
214
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
68
1.77
1.00
2.0
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
107
1.60
1.00
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
107
1.60
1.00
1.3
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
23
2.18
0.98
2.6
4.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
108
1.58
0.97
1.8
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
36
476
0.75
0.94
1.5
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
167
1.45
0.92
1.8
1.7
e6/l
10029.5
13580.4
0.25
19
125
(3045424) Erythrocytes [Presence] in Urine
19
126
1.52
0.91
1.7
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
29
2.08
0.89
1.5
1.1
%
121.3
107.7
—
6
24
(40768797) Stomach Pathology biopsy report
120
1045
1.17
0.84
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
47
1.71
0.80
2.4
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
759
7790
0.89
0.79
4.4
4.1
mmol/l
1.4
1.5
1.98
698
7206
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
33
1.82
0.79
2.8
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
33
1.82
0.79
1.0
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
163
0.61
0.79
1.7
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
98
1.54
0.78
2.1
2.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
243
1.33
0.78
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
191
1.37
0.77
2.1
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
251
2313
1.11
0.76
3.8
4.6
ug/l
2.5
2.5
0.05
233
2070
(40761536) Microorganisms panel - Urine sediment
81
690
1.19
0.75
6.3
3.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
75
1.61
0.75
1.2
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
19
133
1.44
0.74
1.2
1.2
u/l
134.9
37.6
0.37
14
117
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
39
1.80
0.72
5.9
3.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
60
1.67
0.72
2.3
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
77
657
1.19
0.71
1.9
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
185
1686
1.12
0.69
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
240
2220
1.11
0.68
5.4
3.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
61
1.65
0.68
2.2
5.6
%
10.6
11.2
—
10
61
(3009871) Measles virus Ab [Titer] in Serum
5
27
1.86
0.68
1.8
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
127
1.42
0.68
1.6
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
26
196
1.34
0.68
2.2
2.5
ug/min
100.1
110.5
0.08
17
119
(3002523) Influenza virus A Ag [Presence] in Specimen
23
170
1.36
0.68
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
170
1.36
0.68
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
144
1295
1.13
0.67
1.3
1.3
u/ml
5.3
10.6
1.06
48
521
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
191
0.68
0.67
2.1
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
78
1.54
0.65
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
450
1.21
0.65
1.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
44
1.59
0.65
1.0
1.3
ug/l
8.5
6.2
—
7
35
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
120
1.42
0.65
4.7
3.1
nmol/l
0.8
0.9
0.52
11
94
(3004716) Salmonella sp identified in Stool by Organism specific culture
56
470
1.20
0.63
1.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
71
1.56
0.62
1.6
2.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
71
1.56
0.62
1.2
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
8
52
1.54
0.59
1.3
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
25.3
—
0
23
(3016879) Cocaine [Presence] in Urine
47
392
1.21
0.58
3.6
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
54
1.49
0.57
1.6
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
36
1.67
0.56
1.8
1.1
iu/ml
132.9
219.6
—
6
36
(3013512) EKG study
230
2145
1.09
0.56
4.4
3.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
159
1.33
0.55
1.7
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
35
285
1.24
0.54
8.6
2.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
38
1.58
0.54
1.2
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
62
1.46
0.53
1.4
1.5
g/l
1.0
1.0
—
9
62
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
62
1.46
0.53
1.4
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
61
527
1.17
0.52
1.9
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
925
1.13
0.52
3.9
4.2
%
31.1
31.7
0.17
81
631
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
81
718
1.14
0.50
3.3
4.3
ug/l
4.1
29.8
1.48
60
587
(3000012) Reticulocyte production index
6
41
1.47
0.50
1.5
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
5.8
6.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
45
381
1.19
0.49
1.3
1.4
iu/l
35.3
24.4
1.01
35
311
(40768441) Liver Pathology biopsy report
10
68
1.48
0.47
1.9
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
25
309
0.80
0.46
1.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
770
7832
0.93
0.44
4.4
4.2
mmol/l
4.6
4.7
2.25
709
7286
(3000764) Benzodiazepines [Presence] in Urine
49
423
1.17
0.44
3.5
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
274
0.80
0.44
1.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
78
1.41
0.43
1.1
1.4
titre
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
2.6
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
31
1.62
0.43
1.4
12.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
3.0
2.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
217
0.78
0.41
1.4
1.4
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
28.6
—
0
10
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.8
—
0
10
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
114
1.32
0.41
1.7
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
773
7603
1.07
0.41
4.7
4.2
mmol/l
6.0
5.9
0.72
712
6964
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
216
0.78
0.40
1.3
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
93
846
1.11
0.40
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
144
1339
1.09
0.40
2.8
2.9
ug/l
0.8
0.8
0.01
98
831
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
49
428
1.15
0.39
3.5
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
106
1.33
0.39
3.1
2.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
137
0.73
0.39
9.1
2.8
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.7
—
94.2
—
0
12
(3003694) ABO and Rh group [Type] in Blood
244
2319
1.07
0.39
1.5
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
49
430
1.15
0.38
3.5
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
98
1.33
0.37
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
71
1.27
0.36
1.6
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
180
1.23
0.36
1.1
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
14
108
1.30
0.35
3.1
2.7
mmol/l
4.2
4.1
0.46
14
108
(3035285) Chloride [Moles/volume] in Venous blood
14
108
1.30
0.35
3.1
2.7
mmol/l
103.3
105.3
0.38
14
108
(3001019) Free T4 and TSH panel - Serum or Plasma
42
479
0.87
0.35
1.2
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
741
7524
0.94
0.35
4.0
3.7
mmol/l
1.4
1.3
2.19
680
6935
(3044242) Glucose [Moles/volume] in Arterial blood
6
45
1.34
0.33
1.5
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
786
7960
0.94
0.32
4.9
4.5
mmol/l
2.7
2.8
2.94
718
7358
(3049717) Cytology report of Urine Cyto stain
33
288
1.15
0.29
2.8
2.6
—
—
—
0
0
(4094501)
16
195
0.82
0.29
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
110
0.73
0.29
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
40
356
1.13
0.27
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
47
423
1.12
0.27
2.0
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
268
0.85
0.27
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
268
0.85
0.27
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
268
0.85
0.27
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
30
342
0.87
0.27
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
66
1.21
0.26
1.6
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
267
0.86
0.26
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
91
973
0.93
0.25
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
137
0.80
0.24
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
192
1843
1.05
0.24
3.5
4.0
%
21.1
20.9
0.05
81
821
(3000492) Spirometry study
86
806
1.07
0.23
1.9
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
124
0.80
0.21
2.3
3.1
u/ml
3.9
37.2
—
10
117
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.6
—
0
6
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
173.2
—
0
10
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
3.1
—
0
5
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
145
0.83
0.21
1.1
1.1
u/ml
3.1
4.2
—
7
35
(3000285) Sodium [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
13
0.00
0.21
0.0
1.4
—
3.5
—
0
6
(3015183) Erythrocyte sedimentation rate
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
317
1.11
0.20
1.8
1.9
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
50
1.20
0.19
1.2
1.3
—
292.0
—
0
5
(44813793)
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
81
1.24
0.18
3.0
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
53
1.13
0.18
1.5
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
204
1.13
0.18
9.7
4.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
78
1.16
0.15
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
15
131
1.15
0.14
1.9
2.9
umol/l
7.6
7.1
—
8
98
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
284
0.91
0.13
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
90
938
0.96
0.13
1.9
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
221
0.90
0.13
1.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
293
0.92
0.12
1.7
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
167
0.90
0.10
1.2
1.2
—
—
—
0
0
(4034850)
23
249
0.92
0.10
10.7
9.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
96
1.15
0.10
2.7
2.4
pg
33.1
33.2
0.02
11
96
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
97
1.14
0.09
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
134
0.89
0.08
1.0
1.0
u/ml
4.6
2.0
—
5
61
(4281824)
6
71
0.84
0.07
1.7
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
128
1.10
0.06
1.3
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
502
1.04
0.06
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
131
1288
1.02
0.05
1.6
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
90
1.11
0.05
1.0
1.2
nmol/l
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
161
0.93
0.05
1.6
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
150
0.93
0.04
1.1
1.1
u/ml
12.7
5.2
—
8
88
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
199
2008
0.99
0.03
1.8
1.6
mmol/l
1.5
1.4
0.52
173
1712
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
250
1.04
0.03
1.1
1.1
u/ml
1.7
6.8
—
5
33
(3002256) Pathology report gross observation
98
992
0.99
0.02
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
168
0.95
0.02
1.1
1.1
u/ml
0.6
2.9
—
9
75
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
113
1.06
0.02
1.1
1.1
u/ml
2.5
4.5
—
7
43
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
144
0.97
0.00
1.1
1.1
u/ml
1.5
1.4
—
7
68
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
132
0.98
0.00
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
131
0.99
0.00
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
57
0.88
0.00
1.2
1.1
—
7.4
—
0
14
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.8
—
4.6
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
14.3
—
0
6
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
63
0.95
0.00
1.5
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.7
—
2.6
—
0
6
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
63
0.95
0.00
1.5
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
9
0.00
0.00
0.0
1.8
—
0.6
—
0
9
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
9
0.00
0.00
0.0
4.0
—
14.3
—
0
9
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.0
—
1338.4
—
0
5
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
100
1.00
0.00
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ENCEPHOTH and mortality.

Females

Parameter HR [95% CI] p-value
G6_ENCEPHOTH 2.45 [2.02, 2.98] < 0.001
Birth year 0.991 [0.98, 1.0] 0.037

During the follow-up period (1.1.1998 — 31.12.2019), 661 out of 2876 females with G6_ENCEPHOTH died.

Males

Parameter HR [95% CI] p-value
G6_ENCEPHOTH 2.573 [2.12, 3.12] < 0.001
Birth year 0.987 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 676 out of 2598 males with G6_ENCEPHOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_ENCEPHOTH.

N-year risk Females Males
1 0.27% 0.56%
5 1.504% 3.404%
10 3.471% 7.97%
15 6.499% 14.497%
20 10.676% 23.104%

Relationships between endpoints

↥

Index endpoint: G6_ENCEPHOTH – Other encephalitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data